(Q45249138)

English

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial

scientific article published on 25 June 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

0 references

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

Karen A. Krogfelt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Andreas Munk Petersen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hengameh Mirsepasi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sofie Ingdam Halkjær

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Esben Munk Mortensen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Inge Nordgaard-Lassen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

25 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1498-1505

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24972748%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

The role of the fecal stream in Crohn's disease: an historical and analytic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

The Role of Antibiotics in Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Synbiotics and probiotics in the critically ill after the PROPATRIA trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.001

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45249138&oldid=2071318357"